On April 8, Tepnel Life Sciences PLC, officially became part of Gen-Probe (NASDAQ: GPRO), a world leader in molecular diagnostics.
The new, combined entity will continue to offer a broad portfolio of services under the Tepnel Pharmaceutical Services name, as well as Lifecodes and LifeMatch™ transplant diagnostics products, Elucigene™ genetic testing assays, Diaclone immunology products, BIOKITS food safety solutions and Nucleon DNA Extraction products.
More information about Gen-Probe can be found here: www.gen-probe.com.
Latest News
|